Alnylam Pharmaceuticals
Francesca Worthington is an experienced professional in medical communications and publications, currently serving as Associate Director at Alnylam Pharmaceuticals since March 2019, with a maternity leave scheduled from August 2023 to July 2024. Previous roles include Senior Manager and Manager at Lucid, Senior Account Manager at Bedrock Healthcare Communications, and various account management positions at Porterhouse Medical. Francesca's early career involved research at the University of Exeter Medical School, focusing on the SUMMIT study, and marketing at Aston Villa Football Club. Francesca holds a BSc (Hons) degree in Sport and Exercise Science from the University of Birmingham, completed in 2011.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
31 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.